Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients

Alex Iranzo, Ana Fernández-Arcos, Eduard Tolosa, Mónica Serradell, José Luis Molinuevo, Francesc Valldeoriola, Ellen Gelpi, Isabel Vilaseca, Raquel Sánchez-Valle, Albert Lladó, Carles Gaig, Joan Santamaría, Alex Iranzo, Ana Fernández-Arcos, Eduard Tolosa, Mónica Serradell, José Luis Molinuevo, Francesc Valldeoriola, Ellen Gelpi, Isabel Vilaseca, Raquel Sánchez-Valle, Albert Lladó, Carles Gaig, Joan Santamaría

Abstract

Objective: To estimate the risk for developing a defined neurodegenerative syndrome in a large cohort of idiopathic REM sleep behavior disorder (IRBD) patients with long follow-up.

Methods: Using the Kaplan-Meier method, we estimated the disease-free survival rate from defined neurodegenerative syndromes in all the consecutive IRBD patients diagnosed and followed-up in our tertiary referal sleep center between November 1991 and July 2013.

Results: The cohort comprises 174 patients with a median age at diagnosis of IRBD of 69 years and a median follow-up of four years. The risk of a defined neurodegenerative syndrome from the time of IRBD diagnosis was 33.1% at five years, 75.7% at ten years, and 90.9% at 14 years. The median conversion time was 7.5 years. Emerging diagnoses (37.4%) were dementia with Lewy bodies (DLB) in 29 subjects, Parkinson disease (PD) in 22, multiple system atrophy (MSA) in two, and mild cognitive impairment (MCI) in 12. In six cases, in whom postmortem was performed, neuropathological examination disclosed neuronal loss and widespread Lewy-type pathology in the brain in each case.

Conclusions: In a large IRBD cohort diagnosed in a tertiary referal sleep center, prolonged follow-up indicated that the majority of patients are eventually diagnosed with the synucleinopathies PD, DLB and less frequently MSA. IRBD represented the prodromal period of these conditions. Our findings in IRBD have important implications in clinical practice, in the investigation of the early pathological events occurring in the synucleinopathies, and for the design of interventions with potential disease-modifying agents.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Rates of neurological-disease-free-survival according to…
Figure 1. Rates of neurological-disease-free-survival according to the time of IRBD diagnosis in the 174 patients from the cohort.
Figure 2. Rates of neurological-disease-free-survival according to…
Figure 2. Rates of neurological-disease-free-survival according to the time of IRBD diagnosis in the first 44 patients from the cohort (doted line) and the remaining 130 (continuous line).

References

    1. Iranzo A, Santamaria J, Tolosa E (2009) The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 13: 385–401.
    1. Boeve B (2010) REM sleep behavior disorder. Ann NY AcadSci 1184: 15–54.
    1. Arnulf I (2012) REM sleep behavior disorder: motor manifestations and pathophysiology. Mov Disord 27: 677–689.
    1. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 46: 388–393.
    1. Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (IBD): 16 year update on a previously reported series. Sleep Med 14: 744–748.
    1. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, et al. (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72: 1296–1300.
    1. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Martí MJ, et al. (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disease: a descriptive study. Lancet Neurol 5: 572–577.
    1. Iranzo A, Tolosa E, Gellpi E, Molinuevo JL, Valldeoriola F, et al. (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12: 443–453.
    1. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184.
    1. American Psychiatric Association (2000) DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association.
    1. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, et al. (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65: 1863–1872.
    1. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, et al. (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71: 670–676.
    1. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern 256: 183–194.
    1. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
    1. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, et al. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211.
    1. Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, et al. (2008) Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 26: 343–350.
    1. Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Act Neuropathol 115: 709–712.
    1. Tolosa E, Gaig C, Santamaria J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72 Suppl 2 S12–S20.
    1. Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, et al. (2012) Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease. Mov Disord 27: 617–626.
    1. Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69: 811–818.
    1. Postuma RB, Gagnon JF, Vendette M, Montplaisir J (2009) Markers of neurodegeneration in idiopathic REM sleep behaviour disorder and Parkinson disease. Brain 132: 2298–2307.
    1. Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, et al, for the Sleep Innsbruck Barcelona (SINBAR) group (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 9: 1070–1077.
    1. Scherfler C, Frauscher B, Schocke M, Iranzo A, Gschliesser V, et al. (2011) White and gray matter abnormalities in idiopathic REM sleep behaviour disorder. A diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 69: 400–407.
    1. Iranzo A, Serradell M, Vilaseca I, Valldeoriola F, Salamero M, et al. (2013) Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19: 600–606.
    1. Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, et al. (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 10: 797–805.
    1. Aarsland D, Bronnick K, Larsen JP, Tysnes OB (2009) Alves G for the Norwegian Park West Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease. The Norwegian Park West Study. Neurology 72: 1121–1126.
    1. Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian Park West study. JAMA Neurol 70: 580–586.
    1. Molano J, Boeve B, Ferman T, Smith G, Parisi J, et al. (2010) Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinic pathological study. Brain 133: 540–556.
    1. Boot BP, Boeve BF, Roberts RO, Ferman TJ, Geda YE, et al. (2012) Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 71: 49–56.
    1. Schrag A (2002) Epidemiology of movement disorders. In: Jankovic JJ, Tolosa E, eds. Parkinson’s disease and movement disorders. Philadelphia: Lippincott Williams & Wilkins; 73–89.
    1. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, et al. (2004) Dementia with Lewy bodies. Lancet Neurol 3: 19–28.
    1. Wenning GK, Colosimo C, Gesser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3: 93–103.
    1. Morales JM, Bermejo FP, Benito-León J, Rivera-Navarro J, Trincado R, et al. (2004) Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health 118: 426–433.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera